Optimal insulin dosing regimens are difficult to establish with the altered glucose and insulin metabolism associated with ESRD and dialysis5, and concerns regarding hypoglycemia often result in sub-optimal glycemic control. This evidence concerns the gene INS and Hypoglycemia.